This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davies, P. F. Search for Related Content PubMed PubMed Citation Articles by Davies, P. F.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1746.)
© 2004 American Heart Association, Inc.

Editorials

Molecular Phenotypes of Atherosclerosis

Fingering the Perpetrators

Peter F. Davies

From the Institute for Medicine and Engineering and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.

Correspondence to Peter Davies, Director, Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA 19104-6383. E-mail pfd@pobox.upenn.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

The initiation and progression of atherosclerosis appears driven by a combination of genetic and environmental factors. Access to circulating lipoproteins or to molecules shed into the blood from arterial wall cells permits genetic diversity to be evaluated in relation to disease risk; environmental factors are commonly understood to relate to macro-risk such as diet, smoking, etc. However, a more precise and detailed understanding of the genetic and in vivo environment in the immediate vicinity of the predictive, developing, or advanced lesion is desirable. The presence at autopsy of atherosclerotic lesions of varying severity and classifications¹ within the same individual reflects the complexity of this chronic inflammatory process. Furthermore, certain arterial locations are predictive for lesion formation before any detectable pathological change is apparent, whereas other sites appear to be protected.^2,3 Systematic and serendipitous studies of genetic variants associated with atherogenesis have largely been conducted in lipoproteins and blood cells, yet genetic variation in the arterial wall components is an important contributor to disease susceptibility and progression. The most prevalent gene expression changes may identify the inheritance of multiple gene variants as a collection of single nucleotide polymorphisms (SNPs) that may predict both the susceptibility to environmental risk factors and the characteristics of lesion progression. However, the development of molecular signatures that define lesion predisposition, stage of progression, treatment indications, and predicted outcomes is challenging because of spatial and temporal physio(path)ological diversity, even within single vascular beds such as the aorta.

See page 1922

Transcript profiling of atherosclerotic material by DNA . . . [Full Text of this Article]

This article has been cited by other articles:

				R. S. Vasan Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation, May 16, 2006; 113(19): 2335 - 2362. [Full Text] [PDF]

				G. S. Ginsburg, M. P. Donahue, and L. K. Newby Prospects for Personalized Cardiovascular Medicine: The Impact of Genomics J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1615 - 1627. [Abstract] [Full Text] [PDF]